Health ❯Healthcare ❯Clinical Research

Phase 3 Trials

SOUL Trial Patient Outcomes Purpose Studies

Novo Nordisk's CagriSema Falls Short in Latest Weight-Loss Trial for Diabetes Patients

Lenacapavir Injection Offers Breakthrough in HIV Prevention

Novo Nordisk's Oral Semaglutide Shows 14% Reduction in Heart Risks